BioVie Inc. (BIVI) stock
BIVINasdaqPharmaceutical PreparationsFiscal year ends June 30Also trades as BIVIW
$0.94−0.05 (-5.27%)
Close on Nov 18, 2026Market cap $7.11MP/E –Yield –
BioVie revenue
Revenue is the money a company takes in from selling its products and services, before any costs are deducted.
Quarterly revenue
Change is against the same quarter a year earlier.
Periods
| Period | Period end | Value | Change |
|---|---|---|---|
| Q1 FY2017CQ3 2016 | Sep 30, 2016 | $0 | – |
See a number that looks wrong?